-
What value is Artificial Tears Market expected to touch by 2035?
The Artificial Tears Market is expected to reach USD 1542.12 Million by 2035.
-
What CAGR is the Artificial Tears Market expected to exhibit by 2035?
The Artificial Tears Market is expected to exhibit a CAGR of 12.03% by 2035.
-
What are the driving factors of the Artificial Tears Market?
Increasing Prevalence of Dry Eye Syndrome and Growing Awareness of Eye Health to expand the market growth
-
What was the value of the Artificial Tears Market in 2025?
In 2025, the Artificial Tears Market value stood at USD 314.45 Million.
-
Who are some of the prominent players in the Artificial Tears industry?
Top players in the sector include Akorn Inc. (U.S), Johnson and Johnson Services, Inc. (U.S), Similasan Corporation (Switzerland), Aurolab (India), Alcon Inc. (Switzerland), Bayer AG (Germany), OASIS Medical (U.S), Bausch & Lomb (U.S), Santen Pharmaceutical Co., Ltd. (Japan), Ocusoft (U.S), AbbVie Inc. (U.S), Prestige Consumer Healthcare Inc. (U.S), Rohto (Japan), Ursapharm (Germany).
-
Which region is leading in the Artificial Tears Market?
North America is currently leading the Artificial Tears Market.